724.53澳幣4.89(0.68%)
2025/07/15更新
績效 / 1月4.72%
3月15.19%
1年13.81%
晨星評等-
- 1.現金1.70%
- 2.股票12.52%
- 3.債券0.25%
- 4.其他85.53%
- 1.美國85.53%
- 2.新興亞洲5.04%
- 3.歐元區3.80%
- 4.加拿大1.75%
- 5.英國1.38%
- 1.Insmed Inc4.61%
- 2.argenx SE ADR3.99%
- 3.Alnylam Pharmaceuticals Inc3.84%
- 4.Amgen Inc3.66%
- 5.Gilead Sciences Inc3.53%
- 6.Neurocrine Biosciences Inc3.27%
- 7.Regeneron Pharmaceuticals Inc3.20%
- 8.TG Therapeutics Inc2.81%
- 9.BridgeBio Pharma Inc2.71%
- 10.Madrigal Pharmaceuticals Inc2.49%
- 1.現金1.70%
- 2.股票12.52%
- 3.債券0.25%
- 4.其他85.53%
- 1.美國85.53%
- 2.新興亞洲5.04%
- 3.歐元區3.80%
- 4.加拿大1.75%
- 5.英國1.38%
- 1.Insmed Inc4.61%
- 2.argenx SE ADR3.99%
- 3.Alnylam Pharmaceuticals Inc3.84%
- 4.Amgen Inc3.66%
- 5.Gilead Sciences Inc3.53%
- 6.Neurocrine Biosciences Inc3.27%
- 7.Regeneron Pharmaceuticals Inc3.20%
- 8.TG Therapeutics Inc2.81%
- 9.BridgeBio Pharma Inc2.71%
- 10.Madrigal Pharmaceuticals Inc2.49%